PROGRAMME
Wednesday 19 March
12:30-13:30
Registration
13.30-14.30
Opening keynote
Chair: François Moreau Gaudry, Oumeya Adjali
​
13:30 Welcome
​
13:45 Gregory Newby, John Hopkins University
INV01 Title TBC
​
14.30-16.30
Session 1: Advances and challenges for gene editing technology
Chairs:
​
​14:30 Anna Cereseto, University of Trento
INV02: Title TBC
15:00 Aurélie Bedel, University of Bordeaux, INSERM U1312
INV03: Challenges for CRISPR-Cas9 genotoxicity: detection and prevention
​
OR01, OR02, OR03, OR04
16:30-17:00
Coffee Break
17.00-19.00
Session 2: Preclinical and clinical gene editing for gene therapy
Chairs:
​
17:00 Matthew Porteus, Stanford University
INV04 : Title TBC
​
​17:30 Mario Amendola, Genethon, Evry​
INV05 Title TBC
​​
​18:00 Paula Rio, Ciemat/Ciberer, Madrid​
INV06 Title TBC
​
OR05, OR06
20:00
Party at Mama Shelter
Thursday 20 March
08:30-09:00
Registration
09.00-10.45
Session 3: AAV and lentiviral vectors for gene therapy
Chair:
Alessio Cantore, SR-Tiget, Milano
INV07 Title TBC
Hildegard Büning, Hannover Medical School
INV08 Title TBC
OR07, OR08, OR09
10:45-11:15
Coffee Break
11.15-12.45
Session 4: Cancer Therapy I - Immunotherapy and CAR-T cells
Chair:
11:15 Naomi Taylor, Université de Montpellier, NIH
INV09 Title TBC
11:45 Els Verhoeyen, University of Nice
INV10
OR10, OR11​
12:45-13:45
Lunch
13:45-14:45
Poster session
14.45-16.45
Session 5: Disease model : IPSc and organoids cell therapy
Chair:
Olivier Goureau, Institut de la Vision, Paris
INV11 Retinal organoids for modeling inherited retinal diseases and developing new therapeutic strategies
Jens Schwamborn, University of Luxemburg
INV12 Patient specific midbrain organoids and assembloids for in vitro disease modeling
Saverio Tedesco, UCL London​
INV13 Engineering human skeletal muscle for advanced modelling of neuromuscular diseases and gene therapies.
​
OR12, OR13
16:45-17:15
Coffee Break
17.15-18.45
Session 6: Gene therapy for genetic diseases
Chair:
Françoise Piguet, ICM, Paris
INV14 Gene therapy of lysosomal storage disorders
​
Matthias Titeux, Institut Imagine, Paris
INV15 Title TBC
​​
OR14, OR15
18:45-20:15
Poster session 2
Friday 21 March
08:30-09:00
Registration
09.00-10.30
Session 7: Cancer therapy II
Chair:
09:00 Mario Squadrito, SR-Tiget, Milan
INV16 In vivo liver macrophage engineering for cancer immunotherapy
​
09:30 Laurie Menger, Institut Gustave Roussy
INV17 In vivo genome-wide CRISPR screens for advanced T cell therapy
OR16, OR17
10:30-11:00
Coffee Break
11.00-12.45
Session 8: Non-viral vector / nanotechnology for gene editing
Chair:
Jacob Giehm Mikkelsen, Aarhus University
INV18 Title TBC
​
Zoltan Ivics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig
INV19 Title TBC
​​
OR18, OR19, OR20
12:45-14:00
Lunch and posters
14.00-15.45
Session 9: Innovative approaches
Chair:
14:00 Jean-Luc Perfettini, Gustave Roussy, Paris
INV20 Title TBC
​
14:30 Guy Lenaers, Université d'Angers
INV21 Title TBC
​​
OR21, OR22, OR23
16.00-16.45
Session 10: Closing keynote
Chair:
16:00 Alessandro Aiuti, SR-Tiget, Milan
INV22 Title TBC
16:45-17:00
Poster and oral presentation awards